Aquestive Therapeutics, Inc. (AQST)
4.665
-0.16
(-3.22%)
USD |
NASDAQ |
Sep 17, 16:00
4.665
0.00 (0.00%)
After-Hours: 20:00
Aquestive Therapeutics Total Return Level : 4.82 for Sept. 16, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 16, 2026 | 4.82 |
| September 15, 2026 | 4.81 |
| September 14, 2026 | 4.88 |
| September 11, 2026 | 4.78 |
| September 10, 2026 | 4.99 |
| September 09, 2026 | 5.15 |
| September 08, 2026 | 5.21 |
| September 04, 2026 | 5.34 |
| September 03, 2026 | 5.35 |
| September 02, 2026 | 5.38 |
| September 01, 2026 | 5.24 |
| August 31, 2026 | 5.11 |
| August 28, 2026 | 5.02 |
| August 27, 2026 | 5.16 |
| August 26, 2026 | 5.39 |
| August 25, 2026 | 5.08 |
| August 24, 2026 | 4.80 |
| August 21, 2026 | 4.66 |
| August 20, 2026 | 4.495 |
| August 19, 2026 | 4.59 |
| August 18, 2026 | 4.32 |
| August 17, 2026 | 4.29 |
| August 14, 2026 | 4.25 |
| August 13, 2026 | 4.25 |
| August 12, 2026 | 4.23 |
| Date | Value |
|---|---|
| August 11, 2026 | 4.41 |
| August 10, 2026 | 4.29 |
| August 07, 2026 | 3.94 |
| August 06, 2026 | 3.92 |
| August 05, 2026 | 3.755 |
| August 04, 2026 | 3.74 |
| August 03, 2026 | 3.79 |
| July 31, 2026 | 3.695 |
| July 30, 2026 | 3.72 |
| July 29, 2026 | 3.60 |
| July 28, 2026 | 3.76 |
| July 27, 2026 | 3.73 |
| July 24, 2026 | 3.68 |
| July 23, 2026 | 3.77 |
| July 22, 2026 | 3.94 |
| July 21, 2026 | 4.04 |
| July 20, 2026 | 3.945 |
| July 17, 2026 | 4.12 |
| July 16, 2026 | 3.94 |
| July 15, 2026 | 3.95 |
| July 14, 2026 | 4.04 |
| July 13, 2026 | 4.06 |
| July 10, 2026 | 4.12 |
| July 09, 2026 | 4.24 |
| July 08, 2026 | 4.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| LENZ Therapeutics, Inc. | 4.403 |
| ANI Pharmaceuticals, Inc. | 73.59 |
| Corcept Therapeutics, Inc. | 111.81 |
| Veru, Inc. | 2.712 |
| Johnson & Johnson | 637.79 |